Advance Agrolife Q1FY27 profit up 152% as revenue rises

What the company reported for Q1FY27

Advance Agrolife Limited, an agrochemicals company, reported a sharp year-on-year improvement in its standalone numbers for the quarter ended June 30, 2026 (Q1FY27). The board, in a meeting held on August 06, 2026, approved the unaudited standalone financial results for the quarter. The company reported net profit of ₹225.46 million, compared with ₹89.39 million in Q1FY26. Revenue from operations increased to ₹3,304.04 million from ₹1,686.10 million a year earlier. The filing also included board-level changes, subject to shareholder approval.

Revenue growth nearly doubled year-on-year

Advance Agrolife’s revenue from operations for Q1FY27 came in at ₹3,304.04 million. This compares with ₹1,686.10 million in Q1FY26, indicating a substantial scale-up in quarterly sales. Total income for Q1FY27 was ₹3,306.27 million, broadly in line with revenue from operations given relatively small other income. Other income stood at ₹2.23 million in Q1FY27, versus ₹1.35 million in Q1FY26. The company’s total income was also higher than Q4FY26, when total income was ₹1,259.07 million. The quarter’s revenue trajectory therefore reflects both year-on-year and sequential improvement.

Profitability strengthened, with PBT at ₹302.45 million

Profit before tax (PBT) for Q1FY27 was reported at ₹302.45 million. In the year-ago quarter, PBT stood at ₹126.28 million, while Q4FY26 PBT was ₹100.08 million. Net profit rose to ₹225.46 million in Q1FY27 from ₹89.39 million in Q1FY26 and ₹74.61 million in Q4FY26. Total comprehensive income was ₹224.80 million for Q1FY27, compared with ₹89.59 million in Q1FY26 and ₹74.64 million in Q4FY26. The reported basic and diluted EPS for Q1FY27 was ₹3.50. The company also clarified that EPS for the quarters is not annualised.

Expenses rose, led by raw materials consumption

Total expenses for Q1FY27 were ₹3,003.82 million, compared with ₹1,561.17 million in Q1FY26. The company highlighted cost of materials consumed as the primary cost driver at ₹2,673.55 million. Manufacturing and operating expenses were ₹152.71 million, while other expenses were ₹98.52 million. Employee benefits expense stood at ₹44.09 million. Finance costs were ₹20.33 million, and depreciation and amortisation were ₹30.11 million. These line items explain a large part of the expense base reported for the quarter.

Key financials across periods (₹ in millions)

Cost structure snapshot for Q1FY27 (₹ in millions)

Auditor review: unmodified opinion

Advance Agrolife stated that its statutory auditors, S K Patodia & Associates LLP, expressed an unmodified opinion on the reviewed financial results. The results approved by the board were unaudited standalone numbers for the quarter ended June 30, 2026. An unmodified opinion typically indicates that, based on the review, the auditors did not identify material misstatements in the financial information presented. The disclosure is relevant for investors tracking the quality and clarity of quarterly reporting. It also provides a formal comfort point because these are reviewed, not audited, quarterly numbers.

Board changes approved, subject to shareholder vote

Alongside the financial results, the board approved two senior governance changes. The company said it approved the appointment of Mr. Brijmohan Sharma as a Non-Executive Independent Director for a five-year term. It also approved the re-designation of Mr. Narendra Choudhary as Whole-Time Director. Both items were stated to be subject to shareholder approval. The announcement places management and governance updates alongside a quarter of strong financial performance.

Stock snapshot and listed-market metrics cited

The data shared alongside the results included a market snapshot for the company’s listed stock. It referenced NSE: ADVANCE and BSE: 544562, with the sector listed as Pesticides and Agrochemicals. A cited price point showed ₹110.10, up 2.95%, with the day’s high at ₹113 and low at ₹106.2. The 52-week high and low were stated as ₹154 and ₹84.5, respectively. Market capitalisation was shown as ₹707.79 crore, with P/E at 20.06 and P/B at 2.28. Another cited point in the material also referenced a share price of ₹110.74 and market capitalisation of about ₹711.90 crore.

Sector context: peer commentary and monsoon-linked demand

The broader agrochemicals context in the material pointed to demand sensitivity during the Kharif season. It referenced delayed monsoon rains and uneven rainfall affecting crop sowing and demand for crop protection products. In a separate set of results cited, Best Agrolife Limited reported Q1 FY27 revenue of ₹3,960 million and profit after tax of ₹410 million, with a stated strategic shift toward higher-margin patented products. It also cited that patented products accounted for 64% of branded sales in that quarter for Best Agrolife, up from 45% a year earlier. These peer details, while not directly linked to Advance Agrolife’s filing, frame the operating backdrop for agrochemical companies during the quarter.

Why the quarter matters and what to track next

Advance Agrolife’s Q1FY27 results show a large year-on-year jump in both revenue and profit, backed by higher total income and higher operating scale. The expense base also expanded sharply, with raw material consumption forming the largest cost line disclosed. The board’s approval of director appointment and re-designation, subject to shareholder approval, adds a governance layer to the same announcement cycle. Next, investors are likely to track shareholder outcomes on the proposed board changes, and subsequent quarterly updates for continuity in revenue and profitability. The company’s disclosures place Q1FY27 as a strong start to FY27 in reported standalone numbers.